Organogenesis Holdings Inc
General ticker "ORGO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $484.1M
Organogenesis Holdings Inc follows the US Stock Market performance with the rate: 14.1%.
Estimated limits based on current volatility of 4.1%: low 3.05$, high 3.31$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.28$, 4.71$]
- 2024-12-30 to 2025-12-30 estimated range: [2.86$, 5.49$]
Financial Metrics affecting the ORGO estimates:
- Negative: Non-GAAP EPS, $ of 0.04 <= 0.10
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: 1.03 < Operating profit margin, % of 2.89
- Positive: -0.96 < Investing cash flow per share, $ of -0.19
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
- Positive: Interest expense per share, $ of 0.02 <= 0.14
Short-term ORGO quotes
Long-term ORGO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $468.06MM | $450.89MM | $433.14MM |
| Operating Expenses | $395.14MM | $428.59MM | $420.62MM |
| Operating Income | $72.92MM | $22.30MM | $12.53MM |
| Non-Operating Income | $-9.13MM | $-2.02MM | $-2.13MM |
| Interest Expense | $7.24MM | $2.01MM | $2.19MM |
| R&D Expense | $30.74MM | $39.76MM | $44.38MM |
| Income(Loss) | $63.79MM | $20.28MM | $10.39MM |
| Taxes | $-31.12MM | $4.75MM | $5.45MM |
| Profit(Loss) | $94.90MM | $15.53MM | $4.95MM |
| Stockholders Equity | $242.03MM | $265.67MM | $278.66MM |
| Inventory | $25.02MM | $24.78MM | $28.25MM |
| Assets | $443.26MM | $449.36MM | $460.02MM |
| Operating Cash Flow | $61.98MM | $24.86MM | $30.92MM |
| Capital expenditure | $31.22MM | $33.90MM | $24.36MM |
| Investing Cash Flow | $-31.22MM | $-33.90MM | $-24.36MM |
| Financing Cash Flow | $-1.04MM | $-2.20MM | $-5.50MM |
| Earnings Per Share* | $0.73 | $0.12 | $0.04 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.